| Model Number |
BERICHROM HEPARIN |
| Medical Device Problem Code |
Adverse Event Without Identified Device or Use Problem (2993)
|
| Health Effect - Clinical Code |
No Known Impact Or Consequence To Patient (2692)
|
| Date of Event |
04/14/2018
|
|
Type of Reportable Event
|
Malfunction
|
|
Additional Manufacturer Narrative
|
|
The customer contacted siemens customer care center (ccc) and reported that discordant, falsely low heparin unfractionated results were obtained on 2 patient samples using the berichrom heparin reagent.The customer reported that these samples were run before it was time to run quality controls (qcs) and that two other patient samples were processed prior to the affected patient samples without issues.The customer reported that they ran qcs and the affected patient samples after they replaced the reagents with fresh reagents; the qcs and patient results recovered as expected.Siemens is investigating the issue.
|
| |
|
Event or Problem Description
|
|
Discordant, falsely low heparin unfractionated (uf) results were obtained on two patient samples on the bcs xp system using the berichrom heparin reagent.These results were autoverified by the system and sent to the hospital's laboratory information system (lis).The customer noticed that these results were discordant before they were reported to the physician(s).The customer replaced the reagents with fresh reagents and reran the samples; the repeat results were higher than the initial results and were reported, as the correct results, to the physician(s).There are no known reports of patient intervention or adverse health consequences due to the discordant, falsely low heparin uf results.
|
| |
|
Additional Manufacturer Narrative
|
|
Additional information (15-may-2018): siemens investigated the system's data logs and determined that the calibration data recovered acceptably on the day of the event.Siemens observed that the reagent was ejected and loaded 4 times between the initial analysis of sample id (b)(4) and sample id (b)(4) and the purpose of this is unknown.The customer did not provide the time in which the reagent vials were reconstituted and there is no indication that the reagent was on-board past the validated on-board stability time.Siemens determined that the presence of froth, foam, or small bubbles in the reagent vials potentially led to inadequate reagent aspiration, causing the discordant, falsely low heparin unfractionated (uf) results and out of range quality control recoveries.The customer did not provide the affected samples for further investigation and there was no indication of a system or reagent issue.The system and reagent are performing according to specifications.No further evaluation of these devices is required.
|
| |
|
Search Alerts/Recalls
|